Artal Group as of June 30, 2016
Portfolio Holdings for Artal Group
Artal Group holds 60 positions in its portfolio as reported in the June 2016 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Blue Buffalo Pet Prods | 55.4 | $2.7B | 115M | 23.34 | |
Lexicon Pharmaceuticals (LXRX) | 17.0 | $825M | 58M | 14.35 | |
Weight Watchers International | 7.1 | $342M | 29M | 11.63 | |
Goldman Sachs (GS) | 4.5 | $215M | 1.5M | 148.58 | |
Bank of America Corporation (BAC) | 1.7 | $81M | 6.1M | 13.27 | |
Regeneron Pharmaceuticals (REGN) | 1.2 | $59M | 170k | 349.24 | |
Alnylam Pharmaceuticals (ALNY) | 1.2 | $56M | 1.0M | 55.49 | |
Incyte Corporation (INCY) | 1.0 | $50M | 625k | 79.98 | |
Wal-Mart Stores (WMT) | 0.8 | $37M | 500k | 73.02 | |
Biogen Idec (BIIB) | 0.8 | $36M | 150k | 241.82 | |
Alibaba Group Holding (BABA) | 0.7 | $32M | 400k | 79.53 | |
MetLife (MET) | 0.6 | $30M | 750k | 39.83 | |
Alphabet Inc Class A cs (GOOGL) | 0.6 | $28M | 40k | 703.52 | |
BioMarin Pharmaceutical (BMRN) | 0.6 | $27M | 350k | 77.80 | |
Bluebird Bio (BLUE) | 0.5 | $24M | 550k | 43.29 | |
Celgene Corporation | 0.4 | $20M | 200k | 98.63 | |
Nektar Therapeutics (NKTR) | 0.4 | $20M | 1.4M | 14.23 | |
Delphi Automotive | 0.4 | $17M | 275k | 62.60 | |
Kite Pharma | 0.3 | $16M | 325k | 50.00 | |
Tesla Motors (TSLA) | 0.3 | $16M | 75k | 212.28 | |
JPMorgan Chase & Co. (JPM) | 0.3 | $16M | 250k | 62.14 | |
Agios Pharmaceuticals (AGIO) | 0.3 | $16M | 375k | 41.90 | |
International Business Machines (IBM) | 0.3 | $15M | 100k | 151.78 | |
Array BioPharma | 0.3 | $14M | 3.9M | 3.56 | |
Vertex Pharmaceuticals Incorporated (VRTX) | 0.3 | $13M | 150k | 86.02 | |
Us Foods Hldg Corp call (USFD) | 0.2 | $12M | 500k | 24.24 | |
Citigroup (C) | 0.2 | $11M | 250k | 42.39 | |
Morgan Stanley (MS) | 0.2 | $10M | 400k | 25.98 | |
Juno Therapeutics | 0.2 | $9.6M | 250k | 38.44 | |
Seres Therapeutics (MCRB) | 0.2 | $9.0M | 310k | 29.05 | |
Radius Health | 0.1 | $7.4M | 200k | 36.75 | |
Amicus Therapeutics (FOLD) | 0.1 | $6.8M | 1.3M | 5.46 | |
Spectranetics Corporation | 0.1 | $6.5M | 350k | 18.71 | |
Agenus (AGEN) | 0.1 | $6.1M | 1.5M | 4.05 | |
Avexis | 0.1 | $6.2M | 162k | 38.02 | |
Horizon Pharma | 0.1 | $5.8M | 350k | 16.47 | |
Cellectis S A (CLLS) | 0.1 | $5.6M | 210k | 26.59 | |
Jd (JD) | 0.1 | $5.3M | 250k | 21.23 | |
Intellia Therapeutics (NTLA) | 0.1 | $4.8M | 225k | 21.35 | |
Neurocrine Biosciences (NBIX) | 0.1 | $4.3M | 95k | 45.45 | |
Chemocentryx | 0.1 | $4.0M | 900k | 4.49 | |
Ultragenyx Pharmaceutical (RARE) | 0.1 | $3.7M | 75k | 48.91 | |
Ignyta | 0.1 | $4.1M | 750k | 5.42 | |
BioTime | 0.1 | $3.3M | 1.3M | 2.61 | |
Acceleron Pharma | 0.1 | $3.4M | 100k | 33.98 | |
Celldex Therapeutics | 0.1 | $3.0M | 675k | 4.39 | |
Ironwood Pharmaceuticals (IRWD) | 0.1 | $2.8M | 217k | 13.08 | |
Sage Therapeutics (SAGE) | 0.1 | $3.0M | 100k | 30.13 | |
Ophthotech | 0.1 | $2.6M | 50k | 51.04 | |
Spark Therapeutics | 0.1 | $2.6M | 50k | 51.14 | |
Sarepta Therapeutics (SRPT) | 0.0 | $1.9M | 100k | 19.07 | |
Global Blood Therapeutics In | 0.0 | $2.1M | 125k | 16.59 | |
Aegerion Pharmaceuticals | 0.0 | $1.5M | 1.0M | 1.49 | |
Cempra | 0.0 | $1.6M | 100k | 16.49 | |
Nantkwest | 0.0 | $1.4M | 225k | 6.22 | |
Regenxbio Inc equity us cm (RGNX) | 0.0 | $1.6M | 200k | 8.00 | |
Dimension Therapeutics | 0.0 | $1.7M | 275k | 6.00 | |
Ceres | 0.0 | $399k | 1.0M | 0.39 | |
Colucid Pharmaceuticals | 0.0 | $46k | 5.6k | 8.25 | |
Oncocyte | 0.0 | $228k | 64k | 3.56 |